Jacob Ma-Weaver, 10% Owner at MEI Pharma, Inc. (MEIP), bought 32,040 shares at $6.85 ($219K) on 2023-09-22, disclosed to the SEC on 2023-09-25.
Open-market purchase of $219k MEIP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| ABIO | BUY | 2022-05-20 | $30K | — | Filing → |
| ABIO | BUY | 2022-04-27 | $31K | — | Filing → |
| ABIO | BUY | 2022-04-14 | $41K | — | Filing → |